Exclusive special offer and discount title banner vector image

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

SCOPE OF THE REPORT

Asia-Pacific Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilized Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-user (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories) by Geography


MARKET OVERVIEW

The Asia-Pacific amniotic membrane market is estimated to surge with a 7.94% CAGR by 2032, and generate $735.02 million during the forecasting period, 2023-2032.

Asia-Pacific is booming in demand for amniotic membranes owing to the presence of countries such as China, India, and South Korea, which are expected to enter the upcoming product applications market. In China, the increasing number of accidents, cosmetic surgery trends, and the use of amniotic membranes in eye surgery to prevent the use of glasses stimulate market growth.

To Know More About This Report, Request a Free Sample Copy

The Asia-Pacific amniotic membrane market growth analysis entails the evaluation of India, Australia & New Zealand, China, Vietnam, Thailand, South Korea, Japan, Indonesia, and Rest of Asia-Pacific. Japan has well-developed biotechnology sectors and is among the top leading countries. The country has collaborated with various companies across several regions. For instance, in 2018, Japan established the German Pavilion to provide the first common platform for German exhibitors under its ‘Made in Germany’ campaign and events. In addition, the country significantly invests in research and development by collaborating with healthcare capital firms. 

Similarly, Japan has collaborated with United States-based firms and is investing in the development of biotechnology. In 2018, Japan Investment Corporation (JIC) invested heavily in JIC-US initiatives for biotech and drug-discovery startups. Such developments in biotechnology are expected to expand amniotic membrane applications in Japan during the forecast period.

On the other hand, in Indonesia, amniotic membranes have witnessed significant growth in ophthalmology and cancer treatments. Some biologists and medical experts are clinically working on grafts and placenta formation. Moreover, several clinics in Indonesia opt for fresh amniotic membranes for grafts because of their widespread availability. The reliability of using fresh amniotic membranes as a biomaterial is studied due to availability, which boosts the Indonesia amniotic membrane market growth.

The Asia-Pacific amniotic membrane market assessment includes segmentation by product, application, and end-user. Market by product covers lyophilization amniotic membrane and cryopreserved amniotic membrane.

Amniotic membrane transplantation is widely used in dermatological and ophthalmological surgeries to promote wound healing and re-epithelialization. Cryopreserved amniotic membrane (CAM) is a therapy used for patients with ocular surface defects for a whole year. It decreases the need for repeat office visits and is often covered by insurance. In addition to dry eye, CAM may be used to treat chemical burns of the corneal epithelial and ocular surface defects such as those associated with epithelial basement membrane dystrophy, persistent epithelial defects, corneal ulcers, band keratopathy or bullous, recurrent corneal erosions, keratitis, etc.

Furthermore, CAM is widely used in ophthalmology because of its wound-healing, anti-inflammatory, and anti-angiogenic capabilities. Placement of these membranes is not associated with any unexpected long-term effects or significant adverse reactions.

Some of the leading companies operating in the global amniotic membrane market are Smith & Nephew PLC, MiMedx, etc.

Smith & Nephew is a multinational company dedicated to designing and manufacturing medical technology. The company specializes in orthopedics, trauma, advanced wound management, and sports medicine. The company operates globally in Africa, America, Asia-Pacific, Europe, and the Middle East. The company is headquartered in England, United Kingdom, and was founded in 1856.

GrafixPL from Smith & Nephew is developed as a wound cover for a wide variety of acute and chronic wounds in head-to-toe locations. It naturally conforms to complex human anatomies and is used in overexposed joint capsules, tendons, bones, and muscles.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2021
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product, Application, End-User
Countries AnalyzedChina, Japan, India, South Korea, Thailand, Indonesia, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
Companies AnalyzedAmnio Technology LLC, Applied Biologics, BioTissue Inc, Celularity, Corza Ophthalmology, Human Regenerative Technologies LLC, Integra LifeSciences, Labtician Ophthalmics Inc, MiMedx Group Inc, Organogenesis Inc, Smith & Nephew Plc, Skye Biologics LLC, Stryker Corporation, Surgenex LLC, SurgiLogix LLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
    5. MAJOR MARKET FINDINGS
      1. AMNIOTIC MEMBRANE IS MAJORLY USED FOR OCULAR APPLICATIONS
      2. KEY PLAYERS ARE TARGETING ASIA-PACIFIC 
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
      2. GROWING AWARENESS REGARDING NUMEROUS APPLICATIONS OF AMNIOTIC MEMBRANE
      3. RISING DEMAND FOR WOUND CARE TREATMENT 
    2. KEY RESTRAINTS
      1. DIFFICULTIES ASSOCIATED WITH AMNIOTIC MEMBRANE USE
      2. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR CHINA
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY PRODUCT
    1. CRYOPRESERVED AMNIOTIC MEMBRANE
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. LYOPHILIZED AMNIOTIC MEMBRANE
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY APPLICATION
    1. SURGICAL WOUNDS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. OPHTHALMOLOGY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER APPLICATIONS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY END-USER
    1. HOSPITALS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. AMBULATORY SURGICAL CENTERS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. SPECIALIZED CLINICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. RESEARCH CENTERS & LABORATORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET ESTIMATES & SIZES
      2. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET DRIVERS
      3. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET CHALLENGES
      4. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
    2. COMPANY PROFILES
      1. AMNIO TECHNOLOGY LLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      2. APPLIED BIOLOGICS
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
      3. BIOTISSUE INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      4. CELULARITY
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      5. CORZA OPHTHALMOLOGY
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      6. HUMAN REGENERATIVE TECHNOLOGIES LLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      7. INTEGRA LIFESCIENCES
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      8. LABTICIAN OPHTHALMICS INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      9. MIMEDX GROUP INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      10. ORGANOGENESIS INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      11. SMITH & NEPHEW PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      12. SKYE BIOLOGICS LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      13. STRYKER CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      14. SURGENEX LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      15. SURGILOGIX LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST

LIST OF TABLES

TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT – AMNIOTIC MEMBRANE

TABLE 2: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC REGULATORY FRAMEWORK

TABLE 11: KEY PLAYERS OPERATING IN ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET

TABLE 12: LIST OF ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 7: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2023-2032 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZED AMNIOTIC MEMBRANE, 2023-2032 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 10: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2023-2032 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2023-2032 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 14: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTRES, 2023-2032 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2023-2032 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 19: CHINA AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 20: JAPAN AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 21: INDIA AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 22: SOUTH KOREA AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 23: INDONESIA AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 24: THAILAND AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 25: VIETNAM AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 26: AUSTRALIA & NEW ZEALAND AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 27: REST OF ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 28: CELULARITY- COMPANY NET PROFIT, IN 2018-2021 (IN $ MILLION)

FIGURE 29: CELULARITY- COMPANY REVENUE, IN 2018-2021 (IN $ MILLION)

FIGURE 30: INTEGRA LIFESCIENCES- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 31: INTEGRA LIFESCIENCES- COMPANY REVENUE, IN 2017-2021 (IN $ BILLION)

FIGURE 32: MIMEDX GROUP INC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 33: MIMEDX GROUP INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FIGURE 34: ORGANOGENESIS INC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 35: ORGANOGENESIS INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FIGURE 36: SMITH & NEPHEW PLC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 37: SMITH & NEPHEW PLC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FAQ’s